Elequin Capital’s DTRT Health Acquisition Corp. Class A Common Stock DTRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-50,000
Closed -$508K 853
2022
Q3
$508K Hold
50,000
0.19% 44
2022
Q2
$503K Buy
+50,000
New +$502K 0.12% 40

Other funds holding DTRT

Elequin Capital's DTRT Position: Q4 2022 in Review

Elequin Capital sold out of DTRT Health Acquisition Corp. Class A Common Stock (DTRT) in Q4 2022, closing a stake of 50,000 shares — an estimated $508K sold.

Elequin Capital first reported a position in DTRT in Q2 2022 and held it in 2 quarters. The position peaked at $508K in Q3 2022. 17 funds tracked by Wall St. Rank hold DTRT as of Q4 2022.

  • Elequin Capital reported no remaining DTRT Health Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Elequin Capital sold 50,000 DTRT Health Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $508K.
  • Elequin Capital first reported a position in DTRT Health Acquisition Corp. Class A Common Stock in Q2 2022 and held it in 2 quarters.
  • Elequin Capital's DTRT Health Acquisition Corp. Class A Common Stock position peaked at $508K in Q3 2022.
  • 17 funds tracked by Wall St. Rank held DTRT Health Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Elequin Capital's 13F filing for Q4 2022, filed 9 Feb 2023.